DPW
PTCT icon

DiNuzzo Private Wealth’s PTC Therapeutics PTCT Stock Holding History

DiNuzzo Private Wealth’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$979 Hold
12
– – ﹤0.01% 904
2026
Q1 		$818 Hold
12
– – ﹤0.01% 933
2025
Q4 		$912 Buy
12
+2
+20% +$145 ﹤0.01% 907
2025
Q3 		$494 Sell
10
-1
-9% -$52 ﹤0.01% 1094
2025
Q2 		$538 Sell
11
-1
-8% -$47 ﹤0.01% 1049
2025
Q1 		$612 Buy
12
+4
+50% +$200 ﹤0.01% 984
2024
Q4 		$362 Sell
8
-1
-11% -$43 ﹤0.01% 1176
2024
Q3 		$334 Buy
9
+3
+50% +$100 ﹤0.01% 1215
2024
Q2 		$184 Buy
6
+1
+20% +$32 ﹤0.01% 1277
2024
Q1 		$146 Sell
5
-2
-29% -$56 ﹤0.01% 1247
2023
Q4 		$193 Buy
+7
New +$160 ﹤0.01% 1232

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

DiNuzzo Private Wealth's PTCT Position: Q2 2026 in Review

DiNuzzo Private Wealth held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 12 shares worth $979. The position accounts for ﹤0.01% of the portfolio, ranked #904.

DiNuzzo Private Wealth first reported a position in PTCT in Q4 2023 and has held it in 11 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • DiNuzzo Private Wealth held 12 shares of PTC Therapeutics worth $979 as of Q2 2026.
  • DiNuzzo Private Wealth left its PTC Therapeutics share count unchanged in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #904 holding.
  • DiNuzzo Private Wealth first reported a position in PTC Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.